FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ENvue Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026
- Market cap
- $3.08M
- P/E (TTM)
- –
- Dividend yield
- –
ENvue Medical, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENvue [Member] | $184.00K | $119.00K | $193.00K | $351.00K | $49.00K | $103.00K | – | – | – | – | – | – | 77.0% | +275.5% |
| Nano Vibronix [Member] | $55.00K | $534.00K | $119.00K | $371.00K | $445.00K | $922.00K | $444.00K | $376.00K | $817 | – | – | – | 23.0% | -87.6% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano Vibronix [Member] | -$884.00K | -$554.00K | -$387.00K | -$614.00K | -$1.61M | -$612.00K | -$1.37M | -$970.00K | -$674 | – | – | – | -45.1% |
| ENvue [Member] | -$1.51M | -$1.76M | -$13.30M | -$1.13M | -$1.53M | -$441.00K | – | – | – | – | – | – | -1.8% |
| Corporate Segment [Member] | -$3.09M | -$1.39M | $5.26M | -$503.00K | -$835.00K | -$799.00K | – | – | – | – | – | – | +269.5% |
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $233.00K | $490.00K | $377.00K | $694.00K | $462.00K | $986.00K | $403.00K | $349.00K | $794.00K | $905.00K | $1.13M | $445.00K | 97.5% | -49.6% |
| Europe [Member] | $6.00K | $163.00K | – | $8.00K | $8.00K | $9.00K | $9.00K | $8.00K | – | – | $82.00K | $0 | 2.5% | -25.0% |
| Other Country [Member] | – | – | – | $23.99K | $4 | $30.00K | $12.00K | $12.00K | $15 | $12.00K | – | $11.00K | – | – |
| Asia [Member] | – | – | – | – | – | – | – | – | – | – | – | $0 | – | – |
| Australia | – | – | – | – | – | $19.00K | – | – | $8.00K | $4.00K | $4.00K | $2.00K | – | – |
| Australia And New Zealand [Member] | – | – | – | – | – | – | – | $7.00K | – | – | – | $2.00K | – | – |
| Australia New Zealand [Member] | – | – | – | $20.00K | $24.00K | – | $20.00K | $7.00K | $8 | – | – | – | – | – |
From the segment and revenue-disaggregation notes of ENvue Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.